CEL-SCI Corporation
corporate_fare Company Profile
CEL-SCI Corporation (NYSE:CVM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for CVM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 7/10. Recent SEC coverage for CVM spans 8-K.
Recent high-impact activity:
- CEL-SCI's Multikine Wins Saudi NADR Designation; FDA Clinical Hold Still in Place
Financial Snapshot
Short Interest & Short Volume
5.96 days to coverFINRA reported short interest of 705,801 shares in CVM as of the October 30, 2026 settlement, a 6.3% increase from the prior period — about 6.0 days to cover at its recent average daily volume. On November 20, 2026, 48.7% of CVM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.